BMJ Best Practice

参考文献

关键文献

World Health Organization. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. 2005. http://www.who.int/ (last accessed 22 April 2016).

King CK, Glass R, Bresee JS, et al. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep. 2003;52:1-16.

Christopher PR, David KV, John SM, et al. Antibiotic therapy for Shigella dysentery. Cochrane Database Syst Rev. 2010(8):CD006784.

参考文章

1.  Kotloff KL, Winickoff JP, Ivanoff B, et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ. 1999;77:651-666.

2.  Gastrointestinal infections and food poisoning. In: Bannister BA, Gillespie SH, Jones J. Infection: microbiology and management. 3rd ed. Oxford, UK: Blackwell Publishing Ltd.; 2006:167-201.

3.  Centers for Disease Control and Prevention (CDC). National Shigella surveillance. http://www.cdc.gov/ (last accessed 22 April 2016).

4.  Murphy MS. Management of bloody diarrhoea in children in primary care. BMJ. 2008;336:1010-1015.

5.  Centers for Disease Control and Prevention (CDC). Vital signs: incidence and trends of infection with pathogens transmitted commonly through food: foodborne diseases active surveillance network, 10 U.S. sites, 1996-2010. MMWR Morb Mortal Wkly Rep. 2011;60:749-755.

6.  Schroeder GN, Hilbi H. Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. Clin Microbiol Rev. 2008;21:134-156.

7.  Taylor CM. Enterohaemorrhagic Escherichia coli and Shigella dysenteriae type 1-induced haemolytic uraemic syndrome. Pediatr Nephrol. 2008;23:1425-1431.

8.  Yates J. Traveler's diarrhea. Am Fam Physician. 2005;71:2095-2100.

9.  Suzuki T, Sasakawa C. Molecular basis of the intracellular spreading of Shigella. Infect Immun. 2001;69:5959-5966.

10.  Torres AG. Current aspects of Shigella pathogenesis. Rev Latinoam Microbiol. 2004;46:89-97.

11.  World Health Organization. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. 2005. http://www.who.int/ (last accessed 22 April 2016).

12.  King CK, Glass R, Bresee JS, et al. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep. 2003;52:1-16.

13.  Shah N, DuPont HL, Ramsey DJ. Global etiology of travelers' diarrhea: systematic review from 1973 to the present. Am J Trop Med Hyg. 2009;80:609-614.

14.  Hill DR, Ryan ET. Management of travellers' diarrhoea. BMJ. 2008;337:a1746.

15.  Sansonetti PJ. Shigellosis: an old disease in new clothes? PLoS Med. 2006;3:e354.

16.  Wong CS, Jelacic S, Habeeb RL, et al. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med. 2000;342:1930-1936.

17.  Guerrant RL, Van Gilder T, Steiner TS, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis. 2001 Feb 1;32(3):331-51.

18.  Razzaq S. Hemolytic uremic syndrome: an emerging health risk. Am Fam Physician. 2006;74:991-996.

19.  Noris M, Remuzzi G. Hemolytic uremic syndrome. J Am Soc Nephrol. 2005;16:1035-1050.

20.  National Institute for Health and Care Excellence. Diarrhoea and vomiting caused by gastroenteritis in under 5s: diagnosis and management. 2011. http://www.nice.org.uk/ (last accessed 22 April 2016).

21.  UNICEF/WHO. Diarrhoea: why children are still dying and what can be done. 2009. http://www.who.int/ (last accessed 22 April 2016).

22.  Rabbani GH, Ahmed S, Hossain I, et al. Green banana reduces clinical severity of childhood shigellosis: a double-blind, randomized, controlled clinical trial. Pediatr Infect Dis J. 2009;28:420-425.

23.  Christopher PR, David KV, John SM, et al. Antibiotic therapy for Shigella dysentery. Cochrane Database Syst Rev. 2010(8):CD006784.

24.  Srinivasa H, Baijayanti M, Raksha Y. Magnitude of drug resistant Shigellosis: a report from Bangalore. Indian J Med Microbiol. 2009;27:358-360.

25.  Folster JP, Pecic G, Bowen A, et al. Decreased susceptibility to ciprofloxacin among Shigella isolates in the United States, 2006 to 2009. Antimicrob Agents Chemother. 2011;55:1758-1760.

26.  Zhang W, Luo Y, Li J, et al. Wide dissemination of multidrug-resistant Shigella isolates in China. J Antimicrob Chemother. 2011;66:2527-2535.

27.  Vinh H, Anh VT, Anh ND, et al. A multi-center randomized trial to assess the efficacy of gatifloxacin versus ciprofloxacin for the treatment of shigellosis in Vietnamese children. PLoS Negl Trop Dis. 2011;5:e1264.

28.  Costello AM, Bhutta TI. Antidiarrhoeal drugs for acute diarrhoea in children. BMJ. 1992;304:1-2.

29.  Lazzerini M, Ronfani L. Oral zinc for treating diarrhoea in children. Cochrane Database Syst Rev. 2013;(1):CD005436.

30.  Taylor DN, McKenzie R, Durbin A, et al. Rifaximin, a nonabsorbed oral antibiotic, prevents shigellosis after experimental challenge. Clin Infect Dis. 2006;42:1283-1288.

31.  Allen SJ, Martinez EG, Gregorio GV, et al. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev. 2010;(11):CD003048.

32.  Sepp E, Tamm E, Torm S, et al. Impact of a Lactobacillus probiotic on the faecal microflora in children with shigellosis. Microecol Ther. 1995;23:74-80.

33.  Hannu T, Mattila L, Siitonen A, et al. Reactive arthritis attributable to Shigella infection: a clinical and epidemiological nationwide study. Ann Rheum Dis. 2005;64:594-598.

34.  Gwee KA. Postinfectious irritable bowel syndrome. Curr Treat Options Gastroenterol. 2001;4:287-291.

35.  Thabane M, Marshall JK. Post-infectious irritable bowel syndrome. World J Gastroenterol. 2009;15:3591-3596.

36.  Public Health England. Shigella laboratory reports: 1992 to 2013. December 2012. http://www.hpa.org.uk/ (last accessed 22 April 2016).

使用此内容应接受我们的免责声明。